extrahepatic


Also found in: Medical.

ex·tra·he·pat·ic

 (ĕk′strə-hĭ-păt′ĭk)
adj.
Originating or occurring outside the liver.

extrahepatic

(ˌɛkstrəhɪˈpætɪk)
adj
(Medicine) outside the liver
References in periodicals archive ?
The mild elevation of aminotransferases and moderate elevation of ALP can occur due to tumor infiltration or extrahepatic bile duct obstruction.
However in 70% of patients, infection is associated with wide range of clinical manifestations affecting various systems and organs referred as extrahepatic manifestations of chronic HCV infection (EHM).
biliary cysts are classified into the following types: Ia--dilatation of the extrahepatic bile duct (entire); Ib--dilatation of the extrahepatic bile duct (focal segment); Ic--dilatation of the common bile duct portion of extrahepatic bile duct; II--bile duct diverticulum (rarest, with a prevalence of 0.
During the interventional procedure, the extrahepatic arterial blood supply to the cystic lesions was observed in 11 patients (48%); among these patients, 9 received other treatments (needle cyst aspiration or laparoscopic fenestration) before TAE.
Anatomical variations of the extrahepatic biliary tree: review of the world literature.
Furthermore, the mechanisms that affect adhesion molecules and junctional complexes and their significance in primary sclerosing cholangitis and extrahepatic cholestasis are elucidated.
In the diagnosis of choledochal cyst, USG is the best method for evaluating intrahepatic and extrahepatic bile ducts, and gallstones.
The embryologic development of the human biliary tree is a complex process; this is the reason why numerous anatomical variations of intrahepatic and extrahepatic bile ducts have been recognized.
5 In addition, many extrahepatic manifestations are associated with chronic HBV infection.
The orphan drug designation for Yeliva means that Redhill Biopharma can advance its preparations for a Phase IIa study to evaluate the drug's safety and efficacy of Yeliva in patients suffering from unresectable, intrahepatic and extrahepatic cholangiocarcinoma.
000001, the summary random effects were significant in 35 meta-analyses; 31 of these found increased risk with adiposity of esophageal adenocarcinoma, multiple myeloma, and cancers of the colon, rectum, liver, biliary tract system (cancers of gallbladder, extrahepatic bile duct, and ampulla of Vater), pancreas, post-menopausal breast, endometrium, and kidney.
Full browser ?